Concepedia

Wendy Painter

WP

Statistics

Publications

15

Citations

2K

H-Index

13

Active since

2010

Affiliations

Emory University(Current)

Chimerix (United States)

Fred Hutch Cancer Center

University of Liverpool

University of Washington

Wendy Painter is an author at Emory University specializing in antiviral therapy, virology, and antiviral pharmacology.

ORCID

Publications per year

2010–2023

15

Publications

15

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

Wendy Painter, Wayne Holman, Jim Bush et al. · Antimicrobial Agents and Chemotherapy · 2021 · 399 citations · Full text

, , +16

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · Science Translational Medicine · 2021 · 361 citations · Full text

, , +17

Molnupiravir, an Oral Antiviral Treatment for COVID-19

William A. Fischer, Joseph J. Eron, Wayne Holman et al. · medRxiv · 2021 · 218 citations · Full text

, , +16

First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA Viruses

Wendy Painter, Alice Robertson, Lawrence C. Trost et al. · Antimicrobial Agents and Chemotherapy · 2012 · 175 citations · Full text

, , +17

Safety and Efficacy of CMX001 as Salvage Therapy for Severe Adenovirus Infections in Immunocompromised Patients

Diana F. Florescu, Steven A. Pergam, Michael Neely et al. · Biology of Blood and Marrow Transplantation · 2011 · 174 citations · Full text

, , +16

1–5 of 15